MEP36808A - Ambroxol-containing lozenge - Google Patents

Ambroxol-containing lozenge

Info

Publication number
MEP36808A
MEP36808A MEP-368/08A MEP36808A MEP36808A ME P36808 A MEP36808 A ME P36808A ME P36808 A MEP36808 A ME P36808A ME P36808 A MEP36808 A ME P36808A
Authority
ME
Montenegro
Prior art keywords
ambroxol
containing lozenge
lozenge
relates
new type
Prior art date
Application number
MEP-368/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Ulrich Maerz Dr Frieder
Hans-Hermann Von Der Heydt Dr Holger
Schmitt Horst
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP36808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MEP36808A publication Critical patent/MEP36808A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Fats And Perfumes (AREA)
MEP-368/08A 1999-07-20 2000-07-07 Ambroxol-containing lozenge MEP36808A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette
YU3802A RS50246B (sr) 1999-07-20 2000-07-07 Tableta za sisanje, koja sadrži ambroksol

Publications (1)

Publication Number Publication Date
MEP36808A true MEP36808A (en) 2011-02-10

Family

ID=7914872

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-368/08A MEP36808A (en) 1999-07-20 2000-07-07 Ambroxol-containing lozenge

Country Status (33)

Country Link
US (1) US6663889B1 (ru)
EP (2) EP1352646A3 (ru)
JP (1) JP3776041B2 (ru)
KR (1) KR100743846B1 (ru)
CN (1) CN1164263C (ru)
AT (1) ATE246493T1 (ru)
AU (1) AU776906B2 (ru)
BG (1) BG65503B1 (ru)
BR (1) BRPI0012553B8 (ru)
CA (1) CA2379314C (ru)
CZ (1) CZ301981B6 (ru)
DE (2) DE19933148A1 (ru)
DK (1) DK1200070T3 (ru)
EA (1) EA004044B1 (ru)
EE (1) EE04797B1 (ru)
ES (1) ES2173823T3 (ru)
HK (1) HK1045946B (ru)
HR (1) HRP20020050B1 (ru)
HU (1) HU229040B1 (ru)
IL (2) IL147261A0 (ru)
ME (1) MEP36808A (ru)
MX (1) MXPA02000546A (ru)
NO (1) NO331306B1 (ru)
NZ (1) NZ516987A (ru)
PL (1) PL197175B1 (ru)
PT (1) PT1200070E (ru)
RS (1) RS50246B (ru)
SI (1) SI1200070T1 (ru)
SK (1) SK284290B6 (ru)
TR (1) TR200200106T2 (ru)
UA (1) UA73313C2 (ru)
WO (1) WO2001005378A1 (ru)
ZA (1) ZA200200384B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
WO2012085185A1 (en) 2010-12-23 2012-06-28 Advance Holdings Limited Aqueous solution of ambroxol
JP6320931B2 (ja) 2011-12-22 2018-05-09 セントジーン アイピー ゲーエムベーハー リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ
CN109982692A (zh) 2016-11-14 2019-07-05 王明武 用于治疗眼表疾病的制剂和相关方法
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
DE3432411A1 (de) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach Antiadhaesive prohylactica und arzneimittel, enthaltend ein sekretolytisch wirksames benzylaminderivat
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
NZ516987A (en) 2003-08-29
PL352276A1 (en) 2003-08-11
BR0012553B1 (pt) 2014-05-27
PL197175B1 (pl) 2008-03-31
HRP20020050B1 (en) 2004-06-30
EE200200027A (et) 2003-04-15
KR100743846B1 (ko) 2007-08-02
EP1200070B1 (de) 2003-08-06
HRP20020050A2 (en) 2003-06-30
BRPI0012553B8 (pt) 2021-05-25
JP3776041B2 (ja) 2006-05-17
HK1045946A1 (en) 2002-12-20
ES2173823T1 (es) 2002-11-01
CZ301981B6 (cs) 2010-08-25
EA004044B1 (ru) 2003-12-25
DE50003209D1 (de) 2003-09-11
CZ20014633A3 (cs) 2002-03-13
BR0012553A (pt) 2002-04-16
IL147261A0 (en) 2002-08-14
EA200200091A1 (ru) 2002-06-27
HU229040B1 (en) 2013-07-29
ES2173823T3 (es) 2004-04-16
EP1352646A2 (de) 2003-10-15
PT1200070E (pt) 2003-12-31
HK1045946B (zh) 2005-01-28
HUP0202021A3 (en) 2004-05-28
NO20020274L (no) 2002-03-13
AU776906B2 (en) 2004-09-23
CN1364075A (zh) 2002-08-14
SK812002A3 (en) 2002-06-04
EP1352646A3 (de) 2004-01-07
SK284290B6 (sk) 2005-01-03
CA2379314C (en) 2007-09-11
BG65503B1 (bg) 2008-10-31
CA2379314A1 (en) 2001-01-25
TR200200106T2 (tr) 2002-07-22
NO20020274D0 (no) 2002-01-18
NO331306B1 (no) 2011-11-21
ATE246493T1 (de) 2003-08-15
SI1200070T1 (en) 2003-12-31
EE04797B1 (et) 2007-04-16
ZA200200384B (en) 2002-10-30
DE19933148A1 (de) 2001-01-25
RS50246B (sr) 2009-07-15
CN1164263C (zh) 2004-09-01
US6663889B1 (en) 2003-12-16
MXPA02000546A (es) 2002-07-30
JP2003522125A (ja) 2003-07-22
BG106316A (en) 2002-08-30
AU6269900A (en) 2001-02-05
DK1200070T3 (da) 2003-10-06
YU3802A (sh) 2004-09-03
WO2001005378A1 (de) 2001-01-25
HUP0202021A2 (hu) 2002-11-28
IL147261A (en) 2006-12-31
UA73313C2 (ru) 2005-07-15
EP1200070A1 (de) 2002-05-02
KR20020012316A (ko) 2002-02-15

Similar Documents

Publication Publication Date Title
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
LU93311I2 (fr) Mancozèbe, valifenalate
TR200000782T2 (tr) Resorsinol türevleri.
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
SV2002000356A (es) Nuevos derivados de piperazina ref. pc10770aixn/bb
CY1107400T1 (el) Συνταγοποιηση κοκκου μοντελουκαστης
HN1998000175A (es) Imidazotriazininas
CR6393A (es) Moduladores de ccr5
TR200200460T2 (tr) Yeni fenilpiperazinler
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
MEP36808A (en) Ambroxol-containing lozenge
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
HN1998003689A (es) Azetidinas
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
SE9901077D0 (sv) Novel use
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
SE9801494D0 (sv) Novel use
BR9900559A (pt) Composição de vidro de tipo sìlico-sodo-cálcico.
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
ID27733A (id) Metoksiminofenilasetamida
AR037961A1 (es) Aminoplastico compuesto termofraguable, resistente a los rayos uv, su fabricacion y uso
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
NO20024679D0 (no) Krystallinsk farmasöytikum